1. Home
  2. ZLAB vs ESGRO Comparison

ZLAB vs ESGRO Comparison

Compare ZLAB & ESGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ESGRO
  • Stock Information
  • Founded
  • ZLAB 2013
  • ESGRO N/A
  • Country
  • ZLAB China
  • ESGRO Bermuda
  • Employees
  • ZLAB N/A
  • ESGRO 790
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ESGRO Property-Casualty Insurers
  • Sector
  • ZLAB Health Care
  • ESGRO Finance
  • Exchange
  • ZLAB Nasdaq
  • ESGRO Nasdaq
  • Market Cap
  • ZLAB 3.5B
  • ESGRO N/A
  • IPO Year
  • ZLAB 2017
  • ESGRO N/A
  • Fundamental
  • Price
  • ZLAB $29.48
  • ESGRO $20.10
  • Analyst Decision
  • ZLAB Buy
  • ESGRO
  • Analyst Count
  • ZLAB 4
  • ESGRO 0
  • Target Price
  • ZLAB $47.37
  • ESGRO N/A
  • AVG Volume (30 Days)
  • ZLAB 1.3M
  • ESGRO N/A
  • Earning Date
  • ZLAB 05-08-2025
  • ESGRO N/A
  • Dividend Yield
  • ZLAB N/A
  • ESGRO N/A
  • EPS Growth
  • ZLAB N/A
  • ESGRO N/A
  • EPS
  • ZLAB N/A
  • ESGRO N/A
  • Revenue
  • ZLAB $418,326,000.00
  • ESGRO N/A
  • Revenue This Year
  • ZLAB $44.43
  • ESGRO N/A
  • Revenue Next Year
  • ZLAB $48.68
  • ESGRO N/A
  • P/E Ratio
  • ZLAB N/A
  • ESGRO N/A
  • Revenue Growth
  • ZLAB 43.72
  • ESGRO N/A
  • 52 Week Low
  • ZLAB $15.65
  • ESGRO N/A
  • 52 Week High
  • ZLAB $39.77
  • ESGRO N/A
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.03
  • ESGRO 47.89
  • Support Level
  • ZLAB $27.61
  • ESGRO $19.75
  • Resistance Level
  • ZLAB $32.02
  • ESGRO $20.88
  • Average True Range (ATR)
  • ZLAB 1.18
  • ESGRO 0.36
  • MACD
  • ZLAB -0.13
  • ESGRO -0.03
  • Stochastic Oscillator
  • ZLAB 35.72
  • ESGRO 38.64

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ESGRO Enstar Group Limited Depository

Enstar Group Ltd is a (re)insurance group that offers capital release solutions through its network of group companies. It seeks to create value by managing (re)insurance companies and portfolios of (re)insurance and other liability businesses in run-off and striving to generate an attractive risk-adjusted return from its investment portfolio. Its operations are through two reportable segments: Run-off segment and Investments segment.

Share on Social Networks: